Rheumatoid Arthritis

Top Story

Glucocorticoid use tied to increased risk for infection in patients with RA after arthroplasty

May 20, 2019
In the Journals

Increasing tocilizumab dose interval reduces chance of maintaining remission in RA

May 20, 2019
Increasing the dose interval of subcutaneous tocilizumab is associated with a lower chance of maintaining remission after 24 weeks, and is not linked to improved…
In the Journals

Studies could shed light on treatment response in RA

May 17, 2019
A pair of studies by researchers at the Hospital for Special Surgery demonstrate that newly discovered subsets of cells found in joint tissue among patients with…
Meeting News

Interstitial pneumonia may be new category of undifferentiated connective tissue disease

May 10, 2019
DESTIN, Fla. — Interstitial pneumonia with autoimmune features may potentially be the newest category of undifferentiated connective tissue disease, according to…
More Headlines »
ABIM MOC CME

AWIR 2nd Annual Immunology Bootcamp Part 2: T- and B-Cell, IL-12, IL-17, and IL-23 Biology and Inhibitors

This activity is supported by educational grants from AbbVie, Inc.; Amgen; Bristol-Myers Squibb; Pfizer, Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, psoriatic arthritis, vasculitis, and axial…
More »
Video
Meeting News

Heterogeneity still major challenge in connective tissue diseases

May 6, 2019
More »
ABIM MOC CME

AWIR 2nd Annual Immunology Bootcamp Part 1: TNF and IL-6 Biology and Inhibitors

This activity is supported by educational grants from AbbVie, Inc.; Amgen; Bristol-Myers Squibb; Pfizer, Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, psoriatic arthritis, vasculitis, and axial…
More »